Item 2.02. Results of Operations and Financial Condition

On August 6, 2021, Immunic, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2021 and providing a corporate update (the "Press Release").

The information contained in Item 2.02 of this Current Report on Form 8-K, including the Press Release, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, this information shall not be deemed incorporated by reference into any of the Company's filings with the Securities and Exchange Commission, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01. Financial Statements and Exhibits

Exhibit Description

99.1 Press Release, dated August 6, 2021

104 Cover Page to this Current Report on Form 8-K in Inline XBRL

© Edgar Online, source Glimpses